Lynx1 Capital Management LP 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:22 am Purchase | 2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | Lynx1 Capital Management LP | 3,813,926 6.600% | 687,753 (+22.00%) | Filing |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | Lynx1 Capital Management LP | 3,126,173 6.800% | 1,588,828 (+103.35%) | Filing |
| 2022-04-22 4:26 pm Purchase | 2022-04-14 | 13G | Alpine Immune Sciences, Inc. ALPN | Lynx1 Capital Management LP | 1,537,345 5.100% | 1,537,345 (New Position) | Filing |